Source: Eur Respir J, 54 (5) 1900068; 10.1183/13993003.00068-2019
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Michela Bullone, Vitina Carriero, Francesca Bertolini, Anna Folino, Alessandro Mannelli, Antonino Di Stefano, Isabella Gnemmi, Roberto Torchio, Fabio L.M. Ricciardolo. Elevated serum IgE, oral corticosteroid dependence and IL-17/22 expression in highly neutrophilic asthma. Eur Respir J, 54 (5) 1900068; 10.1183/13993003.00068-2019

Member's Comments

No comment yet.

Related content which might interest you: Correlation between specific serum IgE and exhaled NO levels at low and high inhaled corticosteroid use in allergic asthma Source: Eur Respir J 2005; 26: Suppl. 49, 276s Year: 2005 Effect of montelukast administration on serum IL-5 and total IgE levels in asthmatics Source: Eur Respir J 2004; 24: Suppl. 48, 579s Year: 2004 The effects of inhaled steroids, leukotriene receptor antagonists and theophylline on induced sputum cell counts, serum and sputum ECP levels in mild persistent asthma Source: Eur Respir J 2001; 18: Suppl. 33, 261s Year: 2001 Bronchial inflammation without asthma symptoms, relation to low neutrophil activity in serum Source: Eur Respir J 2002; 20: Suppl. 38, 143s Year: 2002 The value of the serum ECP (eosinophil cationic protein) level for monitoring the treatment of allergic bronchial asthma Source: Eur Respir J 2001; 18: Suppl. 33, 268s Year: 2001 Serum eosinophil cationic protein as a potential biomarker for interleukin-5 antibody treatment in patients with severe uncontrolled eosinophilic asthma Source: International Congress 2018 – Biomarkers for evaluating asthma Year: 2018 Short term reductions in inhaled glucocorticoid doses in children with asthma may be associated with increased levels of serum eosinophil protein X Source: Eur Respir J 2001; 18: Suppl. 33, 451s Year: 2001 One year monitoring of children with bronchial asthma and other allergic diseases treated with inhaled corticosteroids vs cromoglycates with serum ECP (S-ECP), FEV1, total IgE and blood eosinophil count - the influence of different therapy Source: Eur Respir J 2002; 20: Suppl. 38, 432s Year: 2002 Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation Source: Eur Respir J, 59 (2) 2100142; 10.1183/13993003.00142-2021 Year: 2022 Serum levels of interleukin-18 in patients affected by allergic bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 30s Year: 2002 Influence of glucocorticosteroids on free and bound metenkefaline levels in serum of children with bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 220s Year: 2002 Serum level of soluble interleukin-2 receptors (sIL-2R) during acute asthma exacerbation, and its relation to severity and response to bronchodilator therapy Source: Eur Respir J 2002; 20: Suppl. 38, 141s Year: 2002 Relationship between CRTH2 mRNA expression in peripheral blood and IgE and eosinophil levels in adult patients with asthma Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019 Elevated serum ECP in wheezing infants predicts the development of atopic asthma Source: Eur Respir J 2002; 20: Suppl. 38, 192s Year: 2002 Free serum IgE suppression with omalizumab and clinical outcomes in asthma Source: International Congress 2019 – Clinical studies of asthma treatments Year: 2019 Serum ECP levels do not correlate with degree of bronchial hyperresponsiveness in patients with cough variant asthma Source: Eur Respir J 2005; 26: Suppl. 49, 584s Year: 2005 Monitoring free serum IgE in asthma patients treated with omalizumab Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010 Regular salbutamol use increases CXCL8 responses in asthma: relationship to the eosinophil response Source: Eur Respir J 2003; 22: 118-126 Year: 2003 YKL-40 in asthmatic patients, and its correlations with exacerbation, eosinophils and immunoglobulin E Source: Eur Respir J 2010; 35: 757-760 Year: 2010 Decreased levels of myeloperoxidase in induced sputum of COPD patients after oral glucocorticoids treatment Source: Eur Respir J 2002; 20: Suppl. 38, 404s Year: 2002